USCDI Export for the Public
| Classification Level Sort descending | Data Class | Data Class Description | Data Element | Data Element Description | Applicable Standards | Submitter Name | Submitter Organization | Submission Date |
|---|---|---|---|---|---|---|---|---|
| Draft USCDI V2 | Harmful or undesired physiological responses associated with exposure to a substance. |
Substance (Drug Class) |
|
|||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Sex (Assigned at Birth) | Birth sex must be coded in accordance with HL7 Version 3 (V3) Standard, Value Sets for AdministrativeGender and NullFlavor attributed as follows:
Adopted at 45 CFR 170.207(n) |
|||||
| Draft USCDI V2 | Tests that result in visual images requiring interpretation by a credentialed professional. |
Imaging Narrative |
Contains a consulting specialist’s interpretation of diagnostic imaging data. This data element was reclassified from Clinical Notes to Diagnostic Imaging. |
Logical Observation Identifiers Names and Codes (LOINC®) version 2.69
|
||||
| Draft USCDI V2 | Analysis of clinical specimens to obtain information about the health of a patient. |
Laboratory Report Narrative |
Contains a consulting specialist’s interpretation of the laboratory report. This data element was reclassified from Clinical Notes to Laboratory. |
|||||
| Draft USCDI V2 | Analysis of clinical specimens to obtain information about the health of a patient. |
Pathology Report Narrative |
Contains a consulting specialist’s interpretation of the pathology report. This data element was reclassified from Clinical Notes to Laboratory. |
|||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Suffix | ||||||
| Draft USCDI V2 | Harmful or undesired physiological responses associated with exposure to a substance. |
Reaction |
|
|||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Middle Name (Including middle initial) | ||||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Previous Name | ||||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Previous Address | Includes street name, number, city/town, state, and zip code. |
|||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Last Name | ||||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
First Name | ||||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Phone Number Type | ||||||
| Draft USCDI V2 | Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease. |
Medications |
|
|||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Email Address | ||||||
| Draft USCDI V2 | Analysis of clinical specimens to obtain information about the health of a patient. |
Values/Results | Documented findings of the analysis of a tested specimen. Includes both structured and unstructured (narrative) components. |
|||||
| Draft USCDI V2 | Analysis of clinical specimens to obtain information about the health of a patient. |
Tests | The name of the analysis of specimens derived from humans which provide information for the diagnosis, prevention, treatment of disease, or assessment of health. |
|
||||
| Draft USCDI V2 | Record of vaccine administration. |
Immunizations |
|
|||||
| Draft USCDI V2 | Narrative patient data relevant to the context identified by note types.
|
History & Physical | Documents the current and past conditions and observations of the patient. |
Logical Observation Identifiers Names and Codes (LOINC®) version 2.69
|
||||
| Draft USCDI V2 | Information related to interactions between healthcare providers and a patient. |
Encounter Type | Joel Andress | Centers for Medicare and Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) |
